Representatives of the institute's staff won prizes in the "Songs of Victory" competition.
10  04.2026
Our institute's staff, as part of a combined choir of regional institutions, took part in a competition of vocalists and choral groups of Rospotrebnadzor institutions and won second place.
World Health Day is celebrated on April 7, 2026.
07  04.2026
The key concept of Health Day is "healthy lifestyle." The 2026 holiday's motto is "Together for Health. Together with Science." The motto is to demonstrate that human health is linked to nutrition, exercise, prevention, ecology, infection safety, and the quality of scientific solutions.

An institute employee presented a report at the Virology Days 2025 forum in St. Petersburg

Home  »  Health education  »  Health education news  »  An institute employee presented a report at the Virology Days 2025 forum in St. Petersburg
Print version
An institute employee presented a report at the Virology Days 2025 forum in St. Petersburg
29  09.2025
The VI International Forum "Days of Virology 2025" was held on September 22-23, 2025.

Over 800 specialists participated in the forum. The program addressed numerous current issues in modern virology, with a strong focus on the treatment and prevention of viral infections.

A separate section of the forum was devoted to the development of new approaches to creating innovative vaccines for the prevention of infectious diseases. Viktor Vladimirovich Novikov, Head of the Immunochemistry Laboratory at the I.N. Blokhina Novosibirsk Research Institute of Epidemiology and Microbiology (Rospotrebnadzor), Honored Scientist of the Russian Federation, Professor, and Doctor of Biological Sciences, delivered a presentation at the section. In his presentation, "Chimeric Norovirus Proteins as the Basis for Antiviral Vaccines," he described our institute's new immunobiotechnological developments aimed at creating innovative vaccines. The Immunochemistry Laboratory, in collaboration with specialists from other departments at the institute, has developed a molecular platform for constructing virus-like particles based on the norovirus capsid protein. Particles constructed from chimeric recombinant proteins can serve as the antigen base for vaccines. Using the developed platform, vaccine prototypes were created for the prevention of COVID-19, norovirus, and echovirus E30, which causes viral serous meningitis.